Recent Finacing
Recent Raise
Novaliq develops ophthalmic formulations using semifluorinated alkanes and EyeSol™ technology to deliver preservative‑free topical eye drops, advancing CyclASol and NOV03 for dry eye and other ocular indications.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investor
See the team members at Novaliq.
